Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Nestec SA, a subsidiary of Nestlé SA, is a Swiss company located in Vevey. The firm manufactures nutrition food products.

Vitalnext brings together the worlds of Life Sciences and consumer products. We develop products with evidence-based health benefits for the ageing population. Healthy Ageing is an important topic in most societies throughout the world. The increasing life expectancy of most people creates a demand for products that keeps us in good health for prolonged periods of time. These products are commercialized via distribution- or licensing agreements with specialized business partners. Vitalnext’s most advanced product is an innovative medical nutrition that aims to not only improve body weight in malnourished people, but also improves the body composition in these patients by a preferential increase in muscle mass.

Part of Danone SA, Nutricia NV is a Dutch company located in Zoetermeer that manufactures dry, condensed and evaporated dairy products.

Biomerix Corp. engages in the development and manufacture of porous polyurethane materials. The company was founded by Steven I. Hochberg, Peter David Constantino, and Andrew Massik in 2001 and is headquartered in New York, NY.

Li Ruike Information Technology (Beijing) Co., Ltd., established on 2010-03-18, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Computer System Services;Basic software service,Application software service;software development;software consulting;product design;model design;Packaging and decoration design;Economic and Trade Consulting;Cultural Consulting;Sports Advice;public relations service;Conference Services;arts and crafts design;computer animation design;buisness planning,design;design,make,acting,Place an ad;market survey;business management;Business Management Consulting;Organize cultural and artistic exchange activities(Does not include commercial performances);literary creation;Undertake exhibition and display activities;Television planning;translation service;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;data processing(Bank Card Center in Data Processing,PUEvalue in1.4Except for the above cloud computing data centers).(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Part of Essetifin SpA, Biosint SpA is a company headquartered in Sermoneta, Italy, that engages in manufacturing of pharmaceutical products. It was founded in 1979.

Advance International Inc. was conceived from the desire to produce a nutritionally superior food product to fight world hunger and malnutrition. Advance International developed and patented a unique, scalable, and highly efficient manufacturing technology that is also green, environmentally friendly, and generates low-to-zero waste. The end product is a nutritionally superior marine based protein powder (called APP) for human consumption from abundant sustainable fish and fish parts. This safe and pharmaceutical style manufacturing technology produces high quality marine protein powder and Omega-3 Oil. APP is a highly pure protein it is flavorless, odorless, non-hygroscopic (stable), and it’s 98% digestible.

A. Nattermann & Cie. GmbH engages in the production of over-the-counter and consumer health care drugs. Its products are sold to distribution firms of the Sanofi group. The company is headquartered in Cologne, Germany.

Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.

sigma-tau is one of the most important Italian pharmaceutical groups, with a major presence also on the international stage. For more than half a century the company has been active in promoting the quality of life of man and his health. sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs. These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products. Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.

Jiaxing Lishan Minglang Biomedical Technology Co., Ltd., established on 1986-09-22, Business scope includes licensed projects:Production of Class III Medical Devices;Cosmetic production;Production of disinfection products for the prevention and control of infectious diseases;Production of hygiene products and single-use medical products;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Production of Class I Medical Devices;Engineering and Technology Research and Experimental Development;Natural science research and experimental development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Health Supplies(non food)Production;Optical Instrument Manufacturing;Manufacturing of daily chemical products;Sales of Class I Medical Devices;Optical Instrument Sales;Health Supplies(non food)Sales;Cosmetics Wholesale;Healthy food(prepackaged)Sales;Sales of hygiene products and single-use medical products;Daily necessities sales;Sales of daily chemical products;Disinfectant sales(Free of Hazardous Chemicals);Machinery and Equipment Leasing;Non-residential real estate leases(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

DSM Nutritional Products AG, a subsidiary of Koninklijke DSM NV, is a company headquartered in Kaiseraugst, Switzerland. The firm manufactures vitamins, carotenoids, and other fine chemicals to the feed, food, pharmaceutical and personal care industries. Dimitri de Vreeze is currently the CEO of the company.

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

Giuliani was founded in 1889 and is a privately-held specialty pharmaceutical company focused on gastroenterology and dermatology. Currently, it markets proprietary products for the treatment and management of ulcerative colitis, Crohn's disease, food intolerances, and dermatological disorders. Giuliani's R&D pipeline consists of new chemical entities and biotechnological products that target inflammatory and autoimmune diseases.

Yuetang is a technology company. They provide an algorithm that connects medical, financial, health, and other fields, predicting the risk of major diseases in each period from the cradle to the last moment of life.

LiveLeaf, Inc. is a private company headquartered in San Carlos, CA. The firm operates as a biotechnology company.\nThe company says this about itself: LiveLeaf,Inc. is a San Francisco Bay Area based company advancing novel therapeutics based on a plant immune biochemistry that is target activated by enzymes of the microbiome and damaged mammalian tissue. LiveLeaf��s patented LiveXtract�� technology is the foundation for currently marketed non-pharmaceutical human and livestock health products targeting gastrointestinal stress. The technology has the potential to transform many plant flavonoids and tannins into immunologically potent ingredients. Grazix Animal Health is a LiveLeaf subsidiary producing LiveXtract-based supplements for cost-effective antibiotic-free livestock production through gut barrier optimization. Quellthera is a LiveLeaf subsidiary advancing the LiveXtract technology platform into novel anti-infective drugs that exploit direct and epigenetic suppression of bacterial virulence.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.